Cytoprotective and antiapoptotic effects of IL-13 in hepatic cold ischemia/reperfusion injury are heme oxygenase-1 dependent

American Journal of Transplantation

Volumn 3, Issue 9, 2003, Pages 1076-1082

  Ke, Bibo ^a   Shen, Xiu Da ^a   Lassman, Charles R ^b   Gao, Feng ^a   Busuttil, Ronald W ^a   Kupiec Weglinski, Jerzy W ^b  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gene therapy; Heme oxygenase 1; IL 13; Ischemia reperfusion injury

Indexed keywords

ADENOVIRUS VECTOR; ASPARTATE AMINOTRANSFERASE; GENE PRODUCT; HEME OXYGENASE 1; INTERLEUKIN 13; PROTEIN A20; PROTEIN BCL 2; PROTEIN BCL XL; PROTOPORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL PROTECTION; COLD INJURY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; GENE THERAPY; GENE TRANSFER; HISTOLOGY; LIVER INJURY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MALE; NICK END LABELING; NONHUMAN; ORGAN DONOR; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SURVIVAL TIME; TH1 CELL;

ANIMALS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; CELL SURVIVAL; ENZYME INHIBITORS; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; IN SITU NICK-END LABELING; INTERLEUKIN-13; LIVER; LIVER CIRCULATION; LIVER TRANSPLANTATION; MALE; METALLOPORPHYRINS; ORGAN PRESERVATION; PROTOPORPHYRINS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SURVIVAL;

EID: 0041861336     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00147.x     Document Type: Article

References (37)

1. Farmer DG, Amersi F, Kupiec-Weglinski JW, Busuttil RW. Current status of ischemia and reperfusion injury in the liver. Transplant Rev 2000; 14: 106-126.
2. Clavien PA, Harvey PRC, Strasberg SM. Preservation and reperfusion injuries in liver allografts: overview and synthesis of current studies. Transplantation 1992; 53: 957-978.
3. Lermasters JJ, Thurman RG. Reperfusion injury after liver preservation for transplantation. Ann Rev Pharmacol Toxicol 1997; 37: 327-338.
4. Ghosh S, May MJ, Kopp EB. NF-κB and Rel proteins: evolutionary conserved mediators of immune response. Ann Rev Immunol 1998; 16: 225-260.
5. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA, Jr. Role of tumor necrosis factor-α in the pathophysiologic alternations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85: 1936-1943.
6. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology 1998; 27: 1172-1177.
7. Colletti LM, Cortis A, Lukacs N, Kunkel SL, Green M, Strieter RM. Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock 1998; 10: 182-191.
8. Kohli V, Selzner M, Madden JF, Bentley RC, Clavien P. A. Endothelial cells and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999; 67: 1099-1105.
9. Gottlieb RA, Burleson KO, Kloner PA, Babior BM, Eugler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994; 94: 1621-1628.
10. Krams SM, Egawa H, Quinn MB et al. Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation 1995; 59: 621-625.
11. Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of prevention injury in rat liver transplantation. Hepatology 1998; 27: 1652-1660.
12. Natori S, Selzner M, Valentino K et al. Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation 1998; 68: 89-96.
13. Sasaki H, Matsuno T, Ishikawa T, Sadamori H, Yagi T, Tanaka N. Activation of apoptosis during early phase of reperfusion after liver transplantation. Transplant Proc 1997; 29: 406-407.
14. Gao W, Washington MC, Bentley RC, Clavein PA. Antiangiogenic agents protect liver sinusoidal lining cells from cold preservation injury in rat liver transplantation. Gastroenterology 1997; 113: 1692-1700.
15. Minty A, Chalon P, Derocq JM et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362: 248-250.
16. Berkman N, John M, Roesems G, Jose P, Barnes PJ, Chung KF. Interleukin 13 inhibits macrophage inflammatory protein-1α production from human alveolar macrophages and monocytes. Am J Respir Cell Mol Biol 1996; 15: 382-389.
17. Muchamuel T, Menon S, Pisacane P, Howard MC, Cockayne DA. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia. correlation with down-modulation of TNF-α, IFN-γ, and IL-12 production. J Immunol 1997; 158: 2898-2903.
18. Mulligan MS, Warner RL, Foreback JL, Shanley TP, Ward PA. Protective effects of IL-4, IL-10, IL-12, and IL-13 in IgG immune complex-induced lung injury. J Immunol 1997; 159: 3483-3489.
19. Woods JM, Amin A, Katschke KJ et al. Interleukin-13 gene therapy reduces inflammation, vascularization, and bony destruction in rat adjuvant-induced arthritis. Hum Gene Ther 2002; 13: 381-393.
20. Manna SK, Aggarwal BB. IL-13 suppresses TNF-induced activation of nuclear factor-κB, activation protein-1, and apoptosis. J Immunol 1998; 161: 2863-2872.
21. Relic B, Guicheux J, Mezin F et al. IL-4 and IL-13, but not IL-10, protect human synoviocytes from apoptosis. J Immunol 2001; 166: 2775-2782.
22. Evans PC, Kilshaw PJ. Interleukin-13 protects endothelial cells from apoptosis and activation: association with the protective genes A20 and A1. Transplantation 2000; 70: 928-934.
23. Ke B, Shen XD, Lassman CR et al. IL-13 gene transfer protects rat livers from antigen-independent injury induced by ischemia and reperfusion. Transplantation 2003; 75: 1118-1123.
24. Ke B, Shen XD, Gao F et al. Heme oxygenase 1 mediates the immunomodulatory and antiapoptotic effects of interleukin 13 gene therapy in vivo and in vitro. Hum Gene Ther 2002; 13: 1845-1857.
25. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Transplantation 1993; 55: 1265-1272.
26. Ke B, Ritter T, Kato H et al. Regulatory cells potentiate the efficacy of IL-4 gene therapy by upregulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients. J Immunol 2000; 164: 5739-5745.
27. Yoshidome H, Kato A, Miyazaki M, Edwards MJ, Lentsch AB. IL-13 activates STAT6 and inhibits liver injury induced by ischemia/reperfusion. Am J Pathol 1999; 155: 1059-1064.
28. Amersi F, Buelow R, Kato H et al. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 1999; 104: 1631-1639.
29. Amersi F, Farmer DG, Shaw GD et al. P-selectin glycoprotein ligand-1 (rPSGL-Ig) mediated blockade of CD62 selectin molecules protects steatotic liver grafts from ischemia/reperfusion injury. Am J Transplant 2002; 2: 600-608.
30. Sawitzki B, Amersi F, Ritter T et al. Upregulation of Bag-1 by ex-vivo gene transfer protects rat livers from ischemia/reperfusion injury. Hum Gene Ther 2002; 13: 1495-1504.
31. Lomo J, Blomhoff HK, Jacobsen SE, Krajewski S, Reed JC, Smeland EB. Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-XI and Mcl-1. Blood 1997; 89: 4415-4424.
32. Honey K, Cobbold SP, Waldmann H. Dominant tolerance and linked suppression induced by therapeutic antibodies do not depend on Fas-FasL interactions. Transplantation 2000; 69: 1683-1689.
33. Wagener ME, Konieczny BT, Dai Z, Ring GH, Lakkis FG. Alloantigen-driven T cell death mediated by Fas ligand and tumor necrosis factor-alpha is not essential for the induction of allograft acceptance. Transplantation 2000; 69: 2428-2432.
34. Shen XD, Ke B, Zhai Y et al. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of STAT4 disruption-mediated cytoprotection. Hepatology 2003; 37: 296-303.
35. Kato H, Amersi F, Buelow R et al. Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant 2001; 1: 121-128.
36. Lee T-S, Chau L-Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002; 8: 240-246.
37. Katori M, Busuttil RW, Kupiec-Weglinski JW. Heme oxygenase 1 system in organ transplantation. Transplantation 2002; 74: 905-912.